ArticleFrontiers in oncology2025
Successful management for vulvar epithelioid sarcoma during pregnancy: a rare case report.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Proximal Epithelioid Sarcoma of the Vulva During Pregnancy: A Case Report and Review of Literature.Clinical case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vulvar epithelioid sarcoma (ES) in pregnancy is an exceedingly rare condition, and only three reports are available to date. Optimal management is not well established. Herein, we report a 35-year-old woman who presented with a tender mass on the left labia majora at 33 weeks and 4 days of gestation. The patient underwent radical local resection of the lesion in the left vulva and left inguinal lymphadenectomy at 36 weeks and 4 days of gestation. Simultaneously, preterm cesarean section was performed because of mature fetus indicated by ultrasonography. Pathology of the lesion demonstrated a 7×5×5 cm-sized ES with the infiltration of surrounding adipose tissue, and no necrosis, hemorrhage, or venous invasion were identified. Six weeks after surgery, the patient underwent tumor resection due to recurrence. Then, adjuvant radiotherapy was performed with a dose of 40 Gy/10 cycles, followed by 15 Gy/3 cycles with a 10×10 cm field. The patient survived with neither recurrence nor complications at a 12-month follow-up. This case highlights management of a rare disease in pregnancy, with radical local resection of the lesion and lymphadenectomy combined with cesarean section.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.